Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |